Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
作者信息
Walker J J, Kaplan D S
机构信息
Department of Medicine, University Hospital, State University of New York Health Science Center, Syracuse.
出版信息
Am J Gastroenterol. 1993 May;88(5):765-7.
PMID:8480746
Abstract
Two patients with severe refractory diabetes-related diarrhea are described. One patient had steatorrhea. Both responded to octreotide during a mean follow-up period of 7 months. The pathophysiology of diabetic diarrhea and the potential mechanism of action of octreotide are discussed. The only adverse side effect reported was hypoglycemia in one of the patients, which required a reduction of the insulin dose. Octreotide is a safe and effective agent for the treatment of refractory diabetic diarrhea.
摘要
相似文献
1
Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
Am J Gastroenterol. 1993 May;88(5):765-7.
2
Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide.
Arch Intern Med. 1994 Aug 22;154(16):1863-7.
3
Efficacy of octreotide but not long-acting somatostatin analogue for severe refractory diabetic diarrhoea.奥曲肽而非长效生长抑素类似物对严重难治性糖尿病腹泻的疗效。
Diabet Med. 2009 Aug;26(8):828-9. doi: 10.1111/j.1464-5491.2009.02766.x.
4
Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue.
Endocr J. 1999 Jun;46(3):477-8.
5
Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.奥曲肽用于治疗直肠癌患者中对洛哌丁胺难治的放化疗引起的腹泻。
Oncology. 2006;71(5-6):354-60. doi: 10.1159/000108593. Epub 2007 Sep 17.
6
Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery.
Tech Coloproctol. 2006 Dec;10(4):346-9. doi: 10.1007/s10151-006-0306-x. Epub 2006 Nov 27.
7
Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation.
Clin Transplant. 1995 Jun;9(3 Pt 1):205-8.
8
Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.奥曲肽长效制剂（LAR）用于治疗与癌症治疗无关的慢性洛哌丁胺难治性腹泻。
Anticancer Res. 2006 May-Jun;26(3B):2325-8.
9
Small intestinal manifestations of diabetes mellitus.糖尿病的小肠表现
Yale J Biol Med. 1983 May-Jun;56(3):189-93.
引用本文的文献
1
Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.
Dig Dis Sci. 1995 Jul;40(7):1464-73. doi: 10.1007/BF02285194.
Zotero 插件